| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/14/2005 | US20050153343 Solid phase synthesis; gene expression libraries; high throughput assay |
| 07/14/2005 | US20050153342 Using cell-adhesion matrix to isolate and propagate tumlor cells; blood filters |
| 07/14/2005 | US20050153341 Apparatus for determining molecular weight |
| 07/14/2005 | US20050153339 Modified shine-dalgarno sequences and methods of use thereof |
| 07/14/2005 | US20050153338 Using polymerase chain chimerization to direct evolution of enhanced biopolymer molecules; directed protein evolution |
| 07/14/2005 | US20050153337 iRNA conjugates |
| 07/14/2005 | US20050153336 Antisense oligonucleotide sequences for use in controlling expression from single transducers and activators of transcription gene (STAT) and treating cell proliferative disorders |
| 07/14/2005 | US20050153335 Expression vector comprising nucleotide sequences coding membrane protein for use in identifying modulator for prevention and treatmment of cell proliferative, inflammatory and nervous system disorders |
| 07/14/2005 | US20050153333 Selective terminal tagging of nucleic acids |
| 07/14/2005 | US20050153332 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 07/14/2005 | US20050153329 Method for determining immune system affecting compounds |
| 07/14/2005 | US20050153328 Method and markers for determining the genotype of horned/polled cattle |
| 07/14/2005 | US20050153326 Method for synthesizing cDNA |
| 07/14/2005 | US20050153324 Exposing a target oligonucleotide to one or more copies of a test oligonucleotide; measuring hybridization; dehybridizing the test oligonucleotide; and repeating until the information content from the hybridization trials equals or exceeds the information content of the target oligonucleotide. |
| 07/14/2005 | US20050153321 Libraries of multiple-ligand-conjugated nucleic acids |
| 07/14/2005 | US20050153320 Single base extension |
| 07/14/2005 | US20050153319 Estrogen receptor gene variation and disease |
| 07/14/2005 | US20050153318 Microarray method of genotyping multiple samples at multiple loci |
| 07/14/2005 | US20050153317 Methods and systems for inferring traits to breed and manage non-beef livestock |
| 07/14/2005 | US20050153316 Methods for quantitative determination of methylation density in a DNA locus |
| 07/14/2005 | US20050153315 Nucleotide sequences coding polypeptide comprising methylarginase activities for use in identifying modulator for prevention and treatment of ischemia-reperfusion injuries, cancer, hypotension, multi-organ failure, arthritis, skin, inflammatory, cardiac and/or migraine disorders |
| 07/14/2005 | US20050153314 Differential gene expression in intestinal polyps |
| 07/14/2005 | US20050153313 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 07/14/2005 | US20050153311 Mass spectrometric immunoassay analysis of specific proteins and variants present in various biological fluids |
| 07/14/2005 | US20050153310 Luciferase biosensor |
| 07/14/2005 | US20050153309 Elongated biosensor for use in collection of cells, bio-fluids and cellular components; probe for detection, diagnosis and treatment of cell proliferative and metabolic disorers |
| 07/14/2005 | US20050153308 Method and materials for polyamine catalyzed bisulfite conversion of cytosine to uracil |
| 07/14/2005 | US20050153307 PNA oligomers, oligomer sets, methods and kits pertaining to the determination of Enterococcus faecalis and other Enterococcus species |
| 07/14/2005 | US20050153306 Libraries; peptide nucleic acids; for assaying hydrolases/proteases |
| 07/14/2005 | US20050153305 Novel proteins and nucleic acids encoding same |
| 07/14/2005 | US20050153304 Multivariate profiling of complex biological regulatory pathways |
| 07/14/2005 | US20050153303 Method of mutagenic chain reaction |
| 07/14/2005 | US20050153302 Method for comprehensive identification of cell lineage specific genes |
| 07/14/2005 | US20050153300 High throughput assay; kits |
| 07/14/2005 | US20050153299 Expression vector comprising nucleotide sequences coding thermophilic bacterium polymerase subunit for use as replication tool during in vitro DNA amplification |
| 07/14/2005 | US20050153298 Protein micro-arrays and multi-layered affinity interaction detection |
| 07/14/2005 | US20050153297 Method for determining oligonucleotide concentration |
| 07/14/2005 | US20050153296 Method and devices for dna methylation analysis |
| 07/14/2005 | US20050153295 Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseases |
| 07/14/2005 | US20050153294 Automated luminescent device which utilizes current variance and thin films to detect and analyze biopolymers; using gene expression patterns to predict disease states |
| 07/14/2005 | US20050153293 Using restriction digestion to generate map physical map genomic map of preferential nucleotide sequence; restriction fragment leng h polymorphisms; single nucleotide polymorphisms |
| 07/14/2005 | US20050153292 Method to determine in vivo nucleic acid levels |
| 07/14/2005 | US20050153290 Normalisation of microarray data based on hybridisation with an internal reference |
| 07/14/2005 | US20050153289 Method of analyzing gene expression |
| 07/14/2005 | US20050153288 Methods for identifying gibberellin responsive genes using cultured vegetable cells |
| 07/14/2005 | US20050153287 Nr3b nmda receptor subunit compositions and related methods |
| 07/14/2005 | US20050153285 Detecting its base pair complementation to a probe nucleic acid bonded to an electrode and a redox marker such as a ferrocyanide, and measuring the redox reaction of the redox marker |
| 07/14/2005 | US20050153284 Using cleavage and dynamic fluid flow through microchannels to determine sequence of preferential polynucleotides |
| 07/14/2005 | US20050153283 Generating circular sequence variants from heteroduplex polynucleotides using non-mismatch-specific nucleases; enhancing allelic variation |
| 07/14/2005 | US20050153282 In vitro nucleic acid amplification reaction any of a first HIV-1 and HIV-2 sequence that may be present and any of a first sequence of the analyte nucleic acid that may be present using a pair of cross-reactive primers and detecting in a hybridization reaction an HIV-1 and or an HIV-2 amplicon |
| 07/14/2005 | US20050153280 Viral propagation system and uses thereof |
| 07/14/2005 | US20050153279 Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 07/14/2005 | US20050153278 Quantitative epstein barr virus PCR rapid assay |
| 07/14/2005 | US20050153277 Bioassay apparatus comprising liquid flowing layer and immobilized coronaviral specific immunoglobulins for use in diagnosis of severe acute respiratory syndrome infection |
| 07/14/2005 | US20050153276 Using matrix of biological signatures to identify modulators of genic expression; bioinformatics |
| 07/14/2005 | US20050153273 Device and methods for monitoring the status of at least one cell |
| 07/14/2005 | US20050153052 Food and beverage quality sensor |
| 07/14/2005 | US20050152926 For immunization and/or diagnosis; eg pneumonia, cardiovascular diseases, atherosclerosis, bronchitis |
| 07/14/2005 | US20050152908 Expressed in blood and useful in diagnosing liver cancer as well as monitoring therapeutic efficacy; polynucleotides; eg amyloid beta (A4) precursor-like protein 2 (APLP2); BCL2-related protein A1 (BCL2A1) |
| 07/14/2005 | US20050152904 Novel P-selectin glycoprotein ligand (PSGL-1) binding protein and uses therefor |
| 07/14/2005 | US20050152860 bone morphogenetic protein 4 (BMP-4) decreases melanin synthesis in melanocytes by decreasing the activity of tyrosinase |
| 07/14/2005 | US20050152838 administering to mammals a Sindbis virus comprising gene that code detectable labels, concurrently with anticarcinogenic agents, and analyzing the amount of cancer cells in the body of the mammal |
| 07/14/2005 | US20050152837 Novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 07/14/2005 | US20050152836 Diagnostic markers and pharmacological targets in heart failure and related reagents and methods of use thereof |
| 07/14/2005 | US20050151973 Optical device utilizing plasmon resonance |
| 07/14/2005 | US20050150763 Biosensor and method of manufacture |
| 07/14/2005 | US20050150762 Biosensor and method of manufacture |
| 07/14/2005 | EP1567637A3 Microreactor architecture and methods |
| 07/14/2005 | DE10361927A1 Ion canal for the development of pharmacological active ingredients, the detection of nerve gas or environmental toxins, comprises a sensor with a perforated substrate layer sandwiched between layers with micro channels |
| 07/14/2005 | DE10361243A1 Untersuchungsverfahren zur Phagozytose Investigation process of phagocytosis |
| 07/14/2005 | DE10359451A1 Improving colorimetric detection of microbes, useful especially for diagnosis of tuberculosis, by using MB 7H9 medium supplemented with animal serum and iodonitrotetrazolium |
| 07/14/2005 | DE10357677A1 Primer und Sonden zum Nachweis genitaler HPV-Genotypen Primers and probes for the detection of genital HPV genotypes |
| 07/14/2005 | DE10131145B4 Zusammensetzung zum zellspezifischen Transfer von Wirkstoffen Composition for cell-specific transfer of drugs |
| 07/14/2005 | CA2592504A1 Classification of cancer |
| 07/14/2005 | CA2551920A1 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 07/14/2005 | CA2551602A1 Methods for controlling sr protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control sr protein activity |
| 07/14/2005 | CA2551560A1 Antibodies for oncogenic strains of hpv and methods of their use |
| 07/14/2005 | CA2551094A1 Methods and compositions for identifying rna-binding proteins |
| 07/14/2005 | CA2551023A1 Maize metallothionein promoter |
| 07/14/2005 | CA2550998A1 Use of fc receptor polymorphisms as diagnostics for treatment strategies for immune-response disorders |
| 07/14/2005 | CA2550962A1 Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients |
| 07/14/2005 | CA2550961A1 Induction of myocardial cell with the use of mammalian bone marrow cell or cord blood-origin cell and fat tissue |
| 07/14/2005 | CA2550933A1 Methods for identifying functional antibodies |
| 07/14/2005 | CA2550730A1 Method and compositions for identifying anti-hiv therapeutic compounds |
| 07/14/2005 | CA2550316A1 Immunoassays, haptens, immunogens and antibodies for anti-hiv therapeutics |
| 07/14/2005 | CA2549948A1 Method for the identification of compounds modulating reverse transport of cholesterol |
| 07/14/2005 | CA2549518A1 Non-androgen dependent roles for androgen receptor and non-androgen related inhibitors of androgen receptor |
| 07/14/2005 | CA2548757A1 Monovalent antibody fragments useful as therapeutics |
| 07/14/2005 | CA2545722A1 Methods of treating asthma |
| 07/14/2005 | CA2541135A1 Methods and kits for predicting an infectious disease state |
| 07/14/2005 | CA2537792A1 Counting biological agents on biological growth plates |
| 07/13/2005 | EP1553515A1 Methods and system for the identification and characterization of peptides and their functional relationships by use of measures of correlation |
| 07/13/2005 | EP1553413A1 Substrate for bioassay, substrate information reader, and substrate information reading method |
| 07/13/2005 | EP1553191A2 Method for judging change in probebearing substrate, probe-bearing substrate and detecting apparatus |
| 07/13/2005 | EP1553190A2 Mutations in and genomic structure of HERG - a long QT syndrome gene |
| 07/13/2005 | EP1553189A1 T7 amplification and cDNA klenow labeling for expression (TAcKLE) analysis with oligonucleotide microarrays |
| 07/13/2005 | EP1553188A1 Use of 4-galactosyl-xylose in humans for the in vivo evaluation of intestinal lactase as a non-invasive diagnostic test of the deficiency of said enzyme |
| 07/13/2005 | EP1553187A1 Method of scavenging intermediate formed by reaction of oxidoreductase with substrate |
| 07/13/2005 | EP1553182A2 Regulated genes and uses thereof |
| 07/13/2005 | EP1553180A1 Nonhuman model animal nonresponsive to endotoxin and lipoprotein or lipopeptide |